Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial.

ABSTRACT:

SUBMITTER: Hoff FW 

PROVIDER: S-EPMC11968959 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature